metastatic castration resistant

Related by string. * Metastatic : metastatic prostate cancer . metastatic pancreatic cancer . metastatic lesions . IV metastatic melanoma / Castration . castrations : castration resistant prostate cancer . advocated chemical castration . surgical castration / RESISTANT . Resistant . resistants : Mine Resistant Ambush Protected . antibiotic resistant bacteria . herbicide resistant weeds * *

Related by context. Frequent words. (Click for all words.) 78 metastatic hormone refractory 73 HER2 positive metastatic breast 72 plus prednisone 71 metastatic renal cell carcinoma 71 castration resistant prostate cancer 70 pertuzumab 70 axitinib 70 FOLFIRI 69 androgen independent 69 abiraterone acetate 69 temsirolimus 69 Erlotinib 69 Nexavar ® 69 HGS ETR1 68 Chronic Hepatitis C 68 relapsed multiple myeloma 68 Asentar 68 Irinotecan 68 dacarbazine 68 Lenalidomide 68 CR# vcMMAE 67 Pivotal Phase 67 relapsed refractory multiple myeloma 67 Clinical Trial Results 67 Acute Myeloid Leukemia AML 67 hormone refractory prostate cancer 67 plus dexamethasone 67 ZYBRESTAT 67 plus gemcitabine 67 tocilizumab 66 refractory multiple myeloma 66 Taxotere ® 66 Bevacizumab 66 Laquinimod 66 Torisel 66 J Am Coll 66 Amrubicin 66 cabazitaxel 66 imatinib mesylate 66 Trastuzumab 66 Voreloxin 66 Monotherapy 66 REVLIMID R 66 Jevtana 66 non squamous 66 Avastin bevacizumab 66 neoadjuvant 66 Phase III Trial 66 lymphoma CTCL 66 interferon alfa 66 vandetanib 66 mycophenolate mofetil 66 Phase 1b trial 65 HRPC 65 decitabine 65 severe renal impairment 65 azacitidine 65 Pirfenidone 65 XELOX 65 cutaneous T cell 65 Pivotal Phase III 65 ARIMIDEX 65 tesmilifene 65 registrational trial 65 nab paclitaxel 65 tanespimycin 65 5 fluorouracil 65 relapsing remitting multiple sclerosis 65 Phase III Clinical Trial 65 phase IIa 64 CoFactor 64 SCH # 64 Alemtuzumab 64 Bortezomib 64 talactoferrin 64 REVLIMID ® 64 unresectable 64 Pivotal Trial 64 humanized anti 64 non alcoholic steatohepatitis 64 resistant ovarian cancer 64 Completes Enrollment 64 androgen deprivation 64 Sorafenib 64 mCRC 64 DAVANAT 64 EGFR expressing metastatic colorectal 64 rNAPc2 64 nitazoxanide 64 Phase IIa trial 64 thymalfasin 64 Cloretazine R VNP#M 64 Gemcitabine 64 Drug Candidate 64 ELND# 64 secondary hyperparathyroidism 64 ocrelizumab 64 PXD# 64 chronic lymphocytic leukemia CLL 64 Azedra 63 Combination therapy

Back to home page